ArticleArchives of dermatological research2025
Distinct anti-microbial peptides expression patterns and microbiome profiles in skin of Tunisian endemic Pemphigus foliaceus patients.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pemphigus foliaceus (PF) is a multifactorial skin disease. Substantial evidence for microbiota dysbiosis in skin disorders was gradually revealed. In PF patients' skin lesions, we characterized the profile of microbial communities and the expression of microbial peptides. Using real-time reverse transcriptase PCR and immunohistochemistry, skin lesions were analyzed for gene and protein expression of human β-defensin (hBD) 1, 2, and 3, cathelicidin (LL-37), RNAse-7, and psoriasin. Bacterial 16S rRNA gene sequencing was used for assessing skin microbial communities in 15 samples from PF patients' lesioned skin and 11 PF patients' non-lesioned skin. Gene expression of hBD 2 and 3 and psoriasin were significantly downregulated in skin samples from remittent patients compared to chronic or de novo diagnosed patients. Protein expression of hBD 2, Psoriasin, and LL-37 was increased in skin from de novo patients compared to skin from healthy donors showing markedly different distribution patterns. The skin microbial analysis revealed a substantial difference in microbiome diversity between lesioned and non-lesioned skin of de novo PF patients and, non-lesioned skin of remittent patients. In addition, microbiome diversity within samples of lesioned skin from de novo PF patients showed lower diversity with a lower abundance of specific bacterial genera, namely Dermabacter, Psychrobacter, and Bradyrhizobium. Thus, there is a noticeable over-representation of Staphylococcus and decreased richness in the bacterial communities of PF-active skin lesions. Our data supports the hypothesis that active skin lesions in PF patients exhibit alterations in skin bacterial diversity interlinked with increased expression of AMPs.
Indexed as
Identifiers
40009223What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.